These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment. Horacek JM; Pudil R; Tichy M; Jebavy L; Strasova A; Ulrychova M; Zak P; Maly J Onkologie; 2008 Oct; 31(10):559-60. PubMed ID: 18854658 [No Abstract] [Full Text] [Related]
6. First, do no harm. Lynce F; Swain SM Onkologie; 2008 Oct; 31(10):511-2. PubMed ID: 18854649 [No Abstract] [Full Text] [Related]
7. Cardiac troponin assays in the management of heart failure. Torre M; Jarolim P Clin Chim Acta; 2015 Feb; 441():92-8. PubMed ID: 25545229 [TBL] [Abstract][Full Text] [Related]
8. Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity. Germanakis I; Anagnostatou N; Kalmanti M Pediatr Blood Cancer; 2008 Sep; 51(3):327-33. PubMed ID: 18523992 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children. Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114 [TBL] [Abstract][Full Text] [Related]
10. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy. Ky B; Carver JR Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884 [TBL] [Abstract][Full Text] [Related]
11. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. Cardinaels EP; Daamen MA; Bekers O; ten Kate J; Niens M; van Suijlen JD; van Dieijen-Visser MP; Brunner-La Rocca HP; Schols JM; Mingels AM J Am Med Dir Assoc; 2015 Oct; 16(10):884-91. PubMed ID: 26255708 [TBL] [Abstract][Full Text] [Related]
12. [Promote multidisciplinary study on anthracycline-induced cardiotoxicity in children]. Chen SB; Huang MR; Tang JY Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):565-8. PubMed ID: 24225284 [No Abstract] [Full Text] [Related]
13. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature. Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478 [TBL] [Abstract][Full Text] [Related]
14. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines. Pourier MS; Kapusta L; van Gennip A; Bökkerink JP; Loonen J; Bellersen L; Mavinkurve-Groothuis AM Clin Chim Acta; 2015 Feb; 441():29-32. PubMed ID: 25512165 [TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options]. Urbanová D; Mladosievicová B Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127 [TBL] [Abstract][Full Text] [Related]
17. Should anthracyclines and dexrazoxane be used for children with cancer? van Dalen EC; van den Berg H; Raphaël MF; Caron HN; Kremer LC Lancet Oncol; 2011 Jan; 12(1):12-3. PubMed ID: 21195321 [No Abstract] [Full Text] [Related]
18. [Usefulness of determining the blood levels of B-type natriuretic peptide in the evaluation of cardiotoxicity in children treated with anthracyclines]. Jackowska T; Wasilewski R Med Wieku Rozwoj; 2006; 10(3 Pt 1):767-74. PubMed ID: 17317907 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of cardiotoxicity induced by anthracyclines. Elliott P Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283 [TBL] [Abstract][Full Text] [Related]
20. Three-month outcome of patients with suspected acute coronary syndrome using point-of-care cardiac troponin-T testing compared with laboratory-based cardiac troponin-T testing: a randomised trial. Asha SE; Cooke A; Walter E; Weaver J Emerg Med J; 2015 Aug; 32(8):601-7. PubMed ID: 25261004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]